This is a preview of subscription content, log in via an institution to check access.
References
Bollee G, Flamant M, Schordan S et al (2011) Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis. Nat Med 17:1242–1250
Bach D, Hauser K, Grabensee B (1996) Long-term clinical course in acute crescentic glomerulonephritis. Int Urol Nephrol 28:439–453
Kain R, Exner M, Brandes R et al (2008) Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 14:1088–1096
Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2:127–137
Citri A, Yarden Y (2006) EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 7:505–516
Schlessinger J (2002) Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 110:669–672
Zeng F, Singh AB, Harris RC (2009) The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology. Exp Cell Res 315:602–610
Holbro T, Civenni G, Hynes NE (2003) The ErbB receptors and their role in cancer progression. Exp Cell Res 284:99–110
Avraham R, Yarden Y (2011) Feedback regulation of EGFR signalling: decision making by early and delayed loops. Nat Rev Mol Cell Biol 12:104–117
Harris R (2011) EGFR signaling in podocytes at the root of glomerular disease. Nat Med 17:1188–1189
Tada H, Sasada R, Kawaguchi Y et al (1999) Processing and juxtacrine activity of membrane-anchored betacellulin. J Cell Biochem 72:423–434
Inui S, Higashiyama S, Hashimoto K et al (1997) Possible role of coexpression of CD9 with membrane-anchored heparin-binding EGF-like growth factor and amphiregulin in cultured human keratinocyte growth. J Cell Physiol 171:291–298
Anklesaria P, Teixido J, Laiho M et al (1990) Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor alpha to epidermal growth factor receptors promotes cell proliferation. Proc Natl Acad Sci USA 87:3289–3293
Iwamoto R, Mekada E (2000) Heparin-binding EGF-like growth factor: a juxtacrine growth factor. Cytokine Growth Factor Rev 11:335–344
Singh AB, Sugimoto K, Dhawan P et al (2007) Juxtacrine activation of EGFR regulates claudin expression and increases transepithelial resistance. Am J Physiol Cell Physiol 293:C1660–C1668
Sakai M, Zhang M, Homma T et al (1997) Production of heparin binding epidermal growth factor-like growth factor in the early phase of regeneration after acute renal injury. Isolation and localization of bioactive molecules. J Clin Invest 99:2128–2138
Yoshizumi M, Kourembanas S, Temizer DH et al (1992) Tumor necrosis factor increases transcription of the heparin-binding epidermal growth factor-like growth factor gene in vascular endothelial cells. J Biol Chem 267:9467–9469
Kume N, Gimbrone MA Jr (1994) Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest 93:907–911
Marikovsky M, Breuing K, Liu PY et al (1993) Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc Natl Acad Sci USA 90:3889–3893
Higashiyama S, Abraham JA, Miller J et al (1991) A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251:936–939
Blotnick S, Peoples GE, Freeman MR et al (1994) T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells. Proc Natl Acad Sci USA 91:2890–2894
Feng L, Garcia GE, Yang Y et al (2000) Heparin-binding EGF-like growth factor contributes to reduced glomerular filtration rate during glomerulonephritis in rats. J Clin Invest 105:341–350
Khong TF, Fraser S, Katerelos M et al (2000) Inhibition of heparin-binding epidermal growth factor-like growth factor increases albuminuria in puromycin aminonucleoside nephrosis. Kidney Int 58:1098–1107
Polihronis M, Murphy BF, Pearse MJ et al (1996) Heparin-binding epidermal growth factor-like growth factor, an immediate-early gene for mesangial cells, is up-regulated in the Thy-1.1 model. Exp Nephrol 4:271–278
Triantafyllopoulou A, Franzke CW, Seshan SV et al (2010) Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages. Proc Natl Acad Sci USA 107:3012–3017
Mitamura T, Higashiyama S, Taniguchi N et al (1995) Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity. J Biol Chem 270:1015–1019
Kunami N, Yotsumoto F, Ishitsuka K et al (2011) Antitumor effects of CRM197, a specific inhibitor of HB-EGF, in T-cell acute lymphoblastic leukemia. Anticancer Res 31:2483–2488
Miyamoto S, Yagi H, Yotsumoto F et al (2006) Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy. Cancer Sci 97:341–347
Hamaoka M, Chinen I, Murata T et al (2010) Anti-human HB-EGF monoclonal antibodies inhibiting ectodomain shedding of HB-EGF and diphtheria toxin binding. J Biochem 148:55–69
Acknowledgments
PRM is funded by Sonderforschungsbereich (SFB) 854, project 1 and ME1365/7-1.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brandt, S., Mertens, P.R. Epidermal growth factor receptor mediates injury in rapidly progressive glomerular disease. Int Urol Nephrol 44, 971–975 (2012). https://doi.org/10.1007/s11255-012-0159-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-012-0159-3